The upcoming Basal-IQ predictive low glucose suspend system (summer 2018 launch expected), plus plans for Control-IQ hybrid closed loop, a mobile app, and the t:sport “...

Read about combo drug Xultophy, Toujeo vs. Tresiba, diabetes apps, the do-it-yourself community, FreeStyle Libre real-world data, and more!

How you can get a copy of Bright Spots & Landmines: The Diabetes Guide I Wish Someone Had Handed Me.

AgaMatrix blood glucose meters and strips by Amazon could make ordering diabetes supplies more convenient and cheaper

An inside look into former Aetna CEO Mark Bertolini's book, "Mission Driven Leadership: My Journey as a Radical Capitalist"

FDA updates Invokana label – the type 2 diabetes therapy now improves heart health in type 2’s with established heart disease in addition to glucose lowering

The latest updates on time-in-range goals for people with all types of diabetes, and insights linking FreeStyle Libre scanning frequency to outcomes.

Resource at DANAtech.org for AADE members with current diabetes device information, news, education, and app reviews; supported by the Helmsley Charitable Trust

MiniMed 780G to add automated correction boluses and Bluetooth, aims to launch by April 2020; Guardian Connect users can now use IQcast on Apple iPhones

Big focus on heart health outcome trials with PIONEER 6 and CAROLINA in the spotlight; plus promising CGM data in adolescents with type 1 diabetes

To commemorate World Obesity Day, we are raising attention on terribly stigmatizing language around obesity and weight

The diaTribe team was on the ground at the 2019 ADA 79th Scientific Sessions to share several of the greatest highlights from the conference!

A new guidance document from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) calls for more patient-centered care and...

Recently announced results from the REWIND and EMPRISE studies show heart protective effects of GLP1-agonist Trulicity and SGLT-2 inhibitor Jardiance in people with and...

The latest on the first automated insulin delivery system with automatic boluses and no-fingersticks CGM. The pivotal trial has been temporarily paused and will resume...

FlowSmart infusion set officially discontinued. On the plus side, BD plans to launch a tubeless type 2 diabetes insulin patch pump starting in late 2019.

Sanofi covers all insulins under this program, including Toujeo, Lantus, Admelog, Apidra.

By Peter Rentzepis and Kelly Close Passing of Dr. Lois Jovanovic, the leading figure in pregnancy and diabetes, brings sorrow to many; friends and colleagues share...

Special occasion meals take special skills to navigate – my top five tips for enjoying Valentine's Day

The first GLP-1 pill for type 2 diabetes offers weight loss and A1C reduction without injections; US decision expected in September 2019, EU decision expected spring of...